Cellular senescence is far more than a simple halt to cell division. Senescent cells remodel their chromatin, rewire their metabolism, degrade proteins differently, and—most notoriously—secrete a cocktail of inflammatory cytokines, growth factors, and matrix-remodeling enzymes called the senescence-associated secretory phenotype, or SASP. This secretory program helps senescent cells recruit immune cells to clear damaged tissue, a process valuable in wound healing and tumor suppression. But when senescent cells linger, as they do in aged organs, the SASP becomes a chronic inflammatory driver implicated in osteoarthritis, atherosclerosis, pulmonary fibrosis, and neurodegeneration. Understanding what controls the SASP is therefore a central question in geroscience, the field devoted to the biology of aging.

The review, authored by a team led by Maryam Bahraminasab and Maha Rashid Al-Roshdi at the University of Nizwa in Oman, tackles a puzzle at the intersection of two stress-response systems. Stress granules form within minutes of translational stress, triggered largely by phosphorylation of the eukaryotic initiation factor eIF2α, which halts the assembly of protein-synthesis initiation complexes. Free messenger RNA then condenses with scaffold proteins such as G3BP1 and G3BP2 and with prion-like proteins like TIA1 and TIAR into liquid-like droplets. Senescence, by contrast, unfolds over days to weeks and involves a different stress architecture, including the DNA damage response, autophagy changes, and profound secretory reprogramming. The authors ask how these two modules interact—and whether the granules are causes, consequences, or mere bystanders of senescence.

Their answer is deliberately nuanced: context determines everything. Different senescence triggers do not produce the same granule response. Oxidative stress from arsenite or ultraviolet radiation robustly induces canonical stress granules even in senescent cells, whereas oncogene-induced senescence and some chemotherapy-driven senescence programs actively impair granule assembly, in part through enhanced autophagy and heat-shock responses that clear or dissolve the condensates. Recent work cited in the review further shows that chronic stress can antagonize granule formation altogether, suggesting that persistent, low-grade stress—the hallmark of aging tissue—may leave cells unable to mount the quick, reversible condensation response that younger cells deploy after acute insults.

One striking finding the review consolidates concerns the RNA-binding protein G3BP1, the master nucleator of stress granules. Rather than universally promoting senescence, G3BP1 appears to counteract it in some settings by sequestering PAI-1, a senescence-promoting factor, inside granules and thereby keeping its activity in check. In cancer contexts, however, G3BP1 has been reported to shape the senescence-associated secretome in ways that influence tumor progression. Recent work on a circular RNA derived from the G3BP1 transcript adds another twist: an m6A-modified circG3BP1 translocates to stress granules, promotes their nucleation, and contributes to senescence-linked chemoresistance. The same protein thus sits on both sides of the senescence ledger, depending on cellular context.

The inflammatory dimension may be where the stakes are highest. Senescent cells can rupture containment of their own chromatin, expelling cytoplasmic chromatin fragments that activate cGAS, the cytosolic DNA sensor, which in turn switches on STING, TBK1, IRF3, and ultimately NF-κB–driven inflammation and interferon-stimulated genes. G3BP1 enters this circuit because it promotes the pre-condensation of cGAS, priming the sensor for rapid responses to invading DNA. Stress granules themselves have been described as shock absorbers that prevent excessive innate immune responses to double-stranded RNA, damping the antiviral signaling machineries that overlap with SASP pathways. In other words, the granule system can either amplify or mute the inflammatory output of a senescent cell, and the review proposes that this dual capacity must be mapped stage by stage rather than assumed.

To bring order to this complexity, the authors introduce a stage-resolved modular framework that assigns context-dependent functions to granule-associated RNA-binding proteins across the arc of senescence—onset, establishment, maintenance, and deep senescence. Each protein is treated as a module with separable roles. USP10, a deubiquitinase that stabilizes p53, influences senescence onset in bone cells and in oncogene-induced programs. HuR, which typically stabilizes pro-growth transcripts, suppresses senescence through autophagy activation in degenerating intervertebral disc tissue. The TIA1/TIAR proteins regulate mitochondrial dynamics, and their loss perturbs respiration and promotes senescence through a microRNA-controlled axis, while newer work shows TIA-1 protects cells via FUNDC1-mediated mitophagy. FXR1 can help cells bypass p53-mediated arrest in oral cancers, whereas the ZFP36 family of RNA-destabilizing proteins, when suppressed, permits lung fibroblast senescence in chronic obstructive pulmonary disease models. TDP-43, famous from amyotrophic lateral sclerosis, prevents chondrocyte senescence when properly localized, and its mislocalization in knock-in mice produces DNA repair defects, inflammation, and neuronal senescence—linking granule biology directly to neurodegenerative aging.

The review also delivers a methodological warning aimed at the field’s own practices. Because stress granules are transient and senescent cells are metabolically idiosyncratic, distinguishing true granules from other RNA-protein condensates requires rigorous markers, appropriate fixation, live-cell confirmation where possible, and standardized senescence induction and validation protocols such as those codified in the MICSE guidelines for minimal information on cellular senescence experimentation. The authors caution that reports of granule loss or persistence in senescence depend heavily on which inducer was used, how senescence was verified with markers like BrdU, EdU, and PCNA, and whether the integrated stress response was actually active—a critical caveat given evidence that senescence can suppress the canonical integrated stress response while still remodel its secretory output.

Therapeutically, the implications are provocative. Senolytic drugs that clear senescent cells, senomorphics that quiet the SASP, and agents such as the integrated stress response inhibitor ISRIB, which has alleviated silica-induced pulmonary fibrosis in mice, all operate near the molecular territory the review maps. If stress granule dynamics gate SASP intensity or cGAS-STING activation, then drugs that tune granule assembly or disassembly—some of which already exist among chemotherapeutics and antiviral condensate modulators—could become senomorphic agents. The authors stop short of prescribing targets, emphasizing instead that granules and their RNA-binding proteins should be regarded as context-dependent components of inflammation-driven senescence rather than universal inducers of senescence onset. That reframing, they argue, is essential for anyone hoping to manipulate aging biology without breaking the stress-adaptation machinery that keeps cells alive in the first place.

Subject of Research: The role of stress granules and RNA-binding proteins in regulating cellular senescence and inflammation

Article Title: Stress granules and RNA-binding proteins in cellular senescence: a modular perspective on stress adaptation and inflammation

Article References: Stress granules and RNA-binding proteins in cellular senescence: a modular perspective on stress adaptation and inflammation. (n.d.). https://doi.org/10.1007/s11033-026-12735-5

Image Credits: AI Generated

DOI: 10.1007/s11033-026-12735-5

Keywords: stress granules, cellular senescence, RNA-binding proteins, SASP, G3BP1, cGAS-STING, inflammation, biomolecular condensates, aging, TDP-43, integrated stress response, autophagy